Nevro earned FDA 510(k) clearance to use its sacroiliac joint fixation system without having to include a lateral screw, the devicemaker said Feb. 28.
Nevro1 has been proven to immediately transfix the sacroiliac joint for long-term fusion, according to a news release. It has self-contained deployable titanium anchors and 3D-printed technology to support bone growth and fusion.
The device will be the company's flagship SI joint fusion product, Nevro CEO Kevin Thornal said in the release.
This is the first clearance since Nevro acquired Vyrsa Technologies and its portfolio of sacroiliac joint products.